Compound information
- Natural Products
- ZC3409833
- Molecular Formula
- C31H28ClN7O2
- Molecular Weight
- 565.199300816 g/mol
- Structure
-
- IUPAC Name
- N-[3-[[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]phenyl]-4-[[(E)-4-(dimethylamino)but-2-enoyl]amino]benzamide
- InChI
- InChI=1S/C31H28ClN7O2/c1-39(2)16-6-11-28(40)35-21-14-12-20(13-15-21)30(41)36-22-7-5-8-23(17-22)37-31-34-19-26(32)29(38-31)25-18-33-27-10-4-3-9-24(25)27/h3-15,17-19,33H,16H2,1-2H3,(H,35,40)(H,36,41)(H,34,37,38)/b11-6+
- InChI Key
- OBJNFLYHUXWUPF-IZZDOVSWSA-N
- SMILES
- CN(C)C/C=C/C(=O)Nc1ccc(C(=O)Nc2cccc(Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)c2)cc1
- Source
- ZINC000149984972
Warheads
- Acrylamide
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 41 | Ring Count | 5 |
Heteroatom Count | 10 | Rotatable Bond Count | 9 |
Hydrogen Bond Acceptor Count | 6 | Hydrogen Bond Donor Count | 4 |
Topological Polar Surface Area | 115.04 Å2 | LogP | 5.017 |
LogS | -6.496 | LogD | 4.17 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.136 | Pgp substrate | 0.395 |
HIA | 0.966 | F20 % | 0.97 |
F30 % | 0.511 | Caco-2 | -5.155 |
MDCK | -5.65 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.001 | PPB | 98.116 |
VD | 1.323 | Fu | 1.899 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.992 | CYP1A2 substrate | 0.76 |
CYP2A6 substrate | 0.255 | CYP2B6 substrate | 0.719 |
CYP2C19 inhibitor | 0.165 | CYP2C19 substrate | 0.835 |
CYP2C8 substrate | 0.909 | CYP2C9 inhibitor | 0.098 |
CYP2C9 substrate | 0.864 | CYP2D6 inhibitor | 0.701 |
CYP2D6 substrate | 0.966 | CYP2E1 substrate | 0.291 |
CYP3A4 inhibitor | 0.797 | CYP3A4 substrate | 0.997 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.343 | CL | 4.866 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.113 | Hepatotoxicity | 0.969 |
Mutagenicity | 0.153 | Rat Oral Acute Toxicity | 0.01 |
FDAMDD | 0.942 | Skin Sensitization | 0.466 |
Carcinogenicity | 0.16 | Eye Corrosion | 0.003 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.908 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.593 | IGC50 | 5.008 |
LC50FM | -7.253 | LC50DM | 1.146 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.277 | NR-AR-LBD | 0.563 |
NR-AhR | 0.994 | NR-Aromatase | 0.833 |
NR-ER | 0.832 | NR-ER-LBD | 0.757 |
NR-PPAR-gamma | 0.951 | SR-ARE | 0.955 |
SR-ATAD5 | 0.869 | SR-HSE | 0.839 |
SR-MMP | 0.959 | SR-p53 | 0.96 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.